Cancer- The breaking news on the treatment, cure and diagnosis of cancer

 
 

 
 

  • Search for "cancer news"
  • $51.09 Million in Sales Expected for Foundation Medicine Inc (FMI) This Quarter

    $51.09 Million in Sales Expected for Foundation Medicine Inc (FMI) This Quarter
    Equities research analysts expect Foundation Medicine Inc to report sales of $51.09 million for the current quarter, according to Zacks . Four analysts have provided estimates for Foundation Medicine's earnings, with the highest sales estimate coming in at $52.80 million and the lowest estimate coming in at $49.80 million.
  • Why are fruits and veggies so important in reducing cancer risk?

    Why are fruits and veggies so important in reducing cancer risk?
    First of all, they have important compounds that reduce inflammation. Plant chemicals that protect plants from environmental stressors are called phytochemicals.
  • Veteran Dodie Blessing remembered for humbly making life better for countless others

    Veteran Dodie Blessing remembered for humbly making life better for countless others
    U.S. Navy Petty Officer Kenji Wheatley, right, presents a flag to Lois Muller, a sister of Dodie Blessing during a celebration of life Monday at the Roseburg National Cemetery Annex. About 100 veterans and well-wishers turned out to honor Blessing who has been described as a pillar to the veteran community.
  • It's all about Hart: Cancer survivor is honorary Relay for Life chair

    It's all about Hart: Cancer survivor is honorary Relay for Life chair
    Michelle Hart is this year's honorary chair of Relay for Life of Jefferson County. She is also a colorectal stage 4 cancer survivor.
  • Viralytics (VRACY) and Its Peers Head-To-Head Contrast

    Viralytics (VRACY) and Its Peers Head-To-Head Contrast
    Viralytics is one of 32 publicly-traded companies in the "Commercial physical research" industry, but how does it contrast to its peers? We will compare Viralytics to similar companies based on the strength of its valuation, profitability, institutional ownership, dividends, analyst recommendations, earnings and risk. This is a breakdown of recent ratings and price targets for Viralytics and its peers, as provided by MarketBeat.com.
  • Biocompare Cancer
  • Tilted Acoustic Tweezers Separate Cells Gently

    Tilted Acoustic Tweezers Separate Cells Gently
    Precise, gentle and efficient cell separation from a device the size of a cell phone may be possible thanks to tilt-angle standing surface acoustic waves, according to a team of engineers.
  • New Biomarker Highly Promising For Predicting Breast Cancer Outcomes

    New Biomarker Highly Promising For Predicting Breast Cancer Outcomes
    A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research published ahead of print in the journal Molecular and Cellular Biology.
  • Finding Keys To Glioblastoma Therapeutic Resistance

    Finding Keys To Glioblastoma Therapeutic Resistance
    Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy. The answer lies not in the DNA sequence of the tumor, but in its epigenetic signature. These findings have been published online as a priority report in the journal Oncotarget.
  • Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs

    Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs
    A revolutionary new scientific method developed at the University of Leeds will improve the diversity of 'biologically active molecules', such as antibiotics and anti-cancer agents.
  • Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma

    Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma
    CINCINNATI - An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children.